On May 5, Ge Longhui Biotech (688098.SH) issued a notice to approve the company's swine fever genetically-engineered subunit vaccine (CHO-133D) as a new veterinary drug and issued a “New Veterinary Drug Registration Certificate” after review by the Ministry of Agriculture and Rural Affairs of China in accordance with the “Veterinary Drug Administration Regulations” and the “Veterinary Drug Registration Measures”.
申联生物(688098.SH)：猪瘟疫苗获批新兽药注册
Shenlian Biotech (688098.SH): Swine Fever Vaccine Approved for New Veterinary Drug Registration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.